Menu
Back to Journals » Infection and Drug Resistance » Volume 4 » default
Infection and Drug Resistance
ISSN: 1178-6973
- View all (3544)
- Volume 17, 2024 (150)
- Volume 16, 2023 (705)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Archive: Volume 4, 2011
A necrotic lung ball caused by co-infection with Candida and Streptococcus pneumoniae
Yokoyama T, Sasaki J, Matsumoto K, Koga C, Ito Y, Kaku Y, Tajiri M, Natori H, Hirokawa M
Infection and Drug Resistance 2011, 4:221-224
Published Date: 15 December 2011
Resistance to antimicrobial drugs in Ghana
Newman MJ, Frimpong E, Donkor ES, Opintan JA, Asamoah-Adu A
Infection and Drug Resistance 2011, 4:215-220
Published Date: 21 December 2011
An Enterobacter plasmid as a new genetic background for the transposon Tn1331
Alavi MR, Antonic V, Ravizee A, Weina PJ, Izadjoo M, Stojadinovic A
Infection and Drug Resistance 2011, 4:209-213
Published Date: 28 November 2011
Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public
Nguyen T, Holdt Henningsen K, Brehaut JC, Hoe E, Wilson K
Infection and Drug Resistance 2011, 4:197-207
Published Date: 20 October 2011
Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora
Honda R, Toshida H, Suto C, Fujimaki T, Kimura T, Ohta T, Murakami A
Infection and Drug Resistance 2011, 4:191-196
Published Date: 20 October 2011
Cumulative clinical experience from over a decade of use of levofloxacin in urinary tract infections: critical appraisal and role in therapy
Bush LM, Chaparro-Rojas F, Okeh V, Etienne J
Infection and Drug Resistance 2011, 4:177-189
Published Date: 18 October 2011
Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran
Ghorashi Z, Ghorashi S, Soltani-Ahari H, Nezami N
Infection and Drug Resistance 2011, 4:171-176
Published Date: 11 October 2011
Meningococcal conjugate vaccines: optimizing global impact
Terranella A, Cohn A, Clark T
Infection and Drug Resistance 2011, 4:161-169
Published Date: 21 September 2011
Review of oral cholera vaccines: efficacy in young children
Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN
Infection and Drug Resistance 2011, 4:155-160
Published Date: 14 September 2011
Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital
Oliveira PR, Paula AP, Dal-Paz K, Felix CS, Rossi F, Silva JS, Lima ALM
Infection and Drug Resistance 2011, 4:149-154
Published Date: 4 August 2011
Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease
Bröker M, Cooper B, DeTora LM, Stoddard JJ
Infection and Drug Resistance 2011, 4:137-147
Published Date: 22 July 2011
Treatment of drug-resistant tuberculosis
Pinto LM, Menzies D
Infection and Drug Resistance 2011, 4:129-135
Published Date: 21 July 2011
Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin
White B, Seaton RA
Infection and Drug Resistance 2011, 4:115-127
Published Date: 24 May 2011
Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, Rossi M, Stricker RB
Infection and Drug Resistance 2011, 4:97-113
Published Date: 3 May 2011
Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
Lida Jafari Saraf, Samuel Eric Wilson
Infection and Drug Resistance 2011, 4:87-95
Published Date: 10 March 2011
Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia
Mary L Townsend, Melanie W Pound, Richard H Drew
Infection and Drug Resistance 2011, 4:77-86
Published Date: 2 March 2011
Patterns of resistance development with integrase inhibitors in HIV
Jean L Mbisa, Supang A Martin, Patricia A Cane
Infection and Drug Resistance 2011, 4:65-76
Published Date: 22 February 2011
Safety and efficacy of entecavir for the treatment of chronic hepatitis B
Melissa Osborn
Infection and Drug Resistance 2011, 4:55-64
Published Date: 3 February 2011
Update on the optimal use of voriconazole for invasive fungal infections
Asma Lat George R Thompson III
Infection and Drug Resistance 2011, 4:43-53
Published Date: 3 February 2011
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
Roger Sordé, Albert Pahissa, Jordi Rello
Infection and Drug Resistance 2011, 4:31-41
Published Date: 25 January 2011
Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges
Brandie D Taylor, Catherine L Haggerty
Infection and Drug Resistance 2011, 4:19-29
Published Date: 20 January 2011
Current treatment of choice for chronic hepatitis C infection
Tareq Yasin, Thomas R Riley, Ian R Schreibman
Infection and Drug Resistance 2011, 4:11-18
Published Date: 12 January 2011
Lyme disease: the next decade
Raphael B Stricker, Lorraine Johnson
Infection and Drug Resistance 2011, 4:1-9
Published Date: 7 January 2011